Avadel Retained Earnings from 2010 to 2024

AVDL Stock  USD 15.75  0.13  0.83%   
Avadel Pharmaceuticals Retained Earnings yearly trend continues to be quite stable with very little volatility. Retained Earnings may rise above about -708.2 M this year. Retained Earnings is the cumulative amount of net income that Avadel Pharmaceuticals PLC retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals
 
Retained Earnings  
First Reported
1996-03-31
Previous Quarter
-745.5 M
Current Value
-772.8 M
Quarterly Volatility
174.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Avadel Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avadel main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 10.4 M or Selling General Administrative of 159.3 M, as well as many exotic indicators such as Price To Sales Ratio of 38.26, Dividend Yield of 0.0 or PTB Ratio of 13.55. Avadel financial statements analysis is a perfect complement when working with Avadel Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Avadel Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Avadel Pharmaceuticals Technical models . Check out the analysis of Avadel Pharmaceuticals Correlation against competitors.

Latest Avadel Pharmaceuticals' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Avadel Pharmaceuticals PLC over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Avadel Pharmaceuticals' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avadel Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (745.5 M)10 Years Trend
Slightly volatile
   Retained Earnings   
       Timeline  

Avadel Retained Earnings Regression Statistics

Arithmetic Mean(363,139,413)
Coefficient Of Variation(53.73)
Mean Deviation144,434,496
Median(320,452,000)
Standard Deviation195,111,734
Sample Variance38068.6T
Range719.8M
R-Value(0.93)
Mean Square Error5429.2T
R-Squared0.87
Slope(40,636,926)
Total Sum of Squares532960.2T

Avadel Retained Earnings History

2024-708.2 M
2023-745.5 M
2022-585.2 M
2021-447.8 M
2020-384.2 M
2019-391.2 M
2018-358 M

Other Fundumenentals of Avadel Pharmaceuticals

Avadel Pharmaceuticals Retained Earnings component correlations

0.71-0.01-0.420.420.130.780.91-0.21-0.01-0.310.080.31-0.530.6-0.260.75-0.710.330.520.50.580.36
0.71-0.33-0.150.12-0.20.10.7-0.410.05-0.12-0.180.05-0.270.65-0.350.73-0.240.140.410.640.710.37
-0.01-0.33-0.14-0.3-0.080.28-0.010.33-0.28-0.210.340.78-0.07-0.160.03-0.010.070.420.240.310.29-0.03
-0.42-0.15-0.14-0.540.03-0.45-0.36-0.10.440.42-0.31-0.640.44-0.050.87-0.120.39-0.85-0.81-0.28-0.39-0.84
0.420.12-0.3-0.540.120.490.30.19-0.020.150.180.0-0.38-0.01-0.320.11-0.540.170.31-0.25-0.150.48
0.13-0.2-0.080.030.120.35-0.17-0.120.490.08-0.18-0.20.37-0.320.22-0.33-0.12-0.32-0.34-0.48-0.4-0.17
0.780.10.28-0.450.490.350.660.07-0.06-0.320.270.39-0.510.26-0.050.4-0.780.330.360.140.190.18
0.910.7-0.01-0.360.3-0.170.66-0.17-0.25-0.280.090.33-0.640.75-0.260.91-0.690.370.520.680.70.28
-0.21-0.410.33-0.10.19-0.120.07-0.170.020.37-0.130.120.03-0.460.07-0.19-0.03-0.08-0.04-0.19-0.27-0.02
-0.010.05-0.280.44-0.020.49-0.06-0.250.020.24-0.36-0.590.48-0.350.46-0.260.04-0.67-0.54-0.39-0.44-0.43
-0.31-0.12-0.210.420.150.08-0.32-0.280.370.24-0.3-0.40.41-0.410.39-0.070.18-0.63-0.59-0.38-0.42-0.37
0.08-0.180.34-0.310.18-0.180.270.09-0.13-0.36-0.30.41-0.30.0-0.120.04-0.060.450.320.090.110.18
0.310.050.78-0.640.0-0.20.390.330.12-0.59-0.40.41-0.380.12-0.550.27-0.130.850.710.610.660.5
-0.53-0.27-0.070.44-0.380.37-0.51-0.640.030.480.41-0.3-0.38-0.720.33-0.50.74-0.52-0.48-0.36-0.39-0.31
0.60.65-0.16-0.05-0.01-0.320.260.75-0.46-0.35-0.410.00.12-0.72-0.150.71-0.480.240.330.580.610.13
-0.26-0.350.030.87-0.320.22-0.05-0.260.070.460.39-0.12-0.550.33-0.15-0.130.09-0.79-0.8-0.44-0.54-0.88
0.750.73-0.01-0.120.11-0.330.40.91-0.19-0.26-0.070.040.27-0.50.71-0.13-0.470.240.370.770.740.1
-0.71-0.240.070.39-0.54-0.12-0.78-0.69-0.030.040.18-0.06-0.130.74-0.480.09-0.47-0.23-0.21-0.1-0.13-0.09
0.330.140.42-0.850.17-0.320.330.37-0.08-0.67-0.630.450.85-0.520.24-0.790.24-0.230.890.550.640.74
0.520.410.24-0.810.31-0.340.360.52-0.04-0.54-0.590.320.71-0.480.33-0.80.37-0.210.890.590.70.89
0.50.640.31-0.28-0.25-0.480.140.68-0.19-0.39-0.380.090.61-0.360.58-0.440.77-0.10.550.590.970.29
0.580.710.29-0.39-0.15-0.40.190.7-0.27-0.44-0.420.110.66-0.390.61-0.540.74-0.130.640.70.970.46
0.360.37-0.03-0.840.48-0.170.180.28-0.02-0.43-0.370.180.5-0.310.13-0.880.1-0.090.740.890.290.46
Click cells to compare fundamentals

About Avadel Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Avadel Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Avadel Pharmaceuticals investors use historical funamental indicators, such as Avadel Pharmaceuticals's Retained Earnings, to determine how well the company is positioned to perform in the future. Although Avadel Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Avadel Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Avadel Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Avadel Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Avadel Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Retained Earnings-745.5 M-708.2 M
Retained Earnings Total Equity-403 M-423.1 M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Avadel Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Avadel Pharmaceuticals is a strong investment it is important to analyze Avadel Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avadel Pharmaceuticals' future performance. For an informed investment choice regarding Avadel Stock, refer to the following important reports:
Check out the analysis of Avadel Pharmaceuticals Correlation against competitors.
Note that the Avadel Pharmaceuticals information on this page should be used as a complementary analysis to other Avadel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Avadel Stock analysis

When running Avadel Pharmaceuticals' price analysis, check to measure Avadel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avadel Pharmaceuticals is operating at the current time. Most of Avadel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Avadel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avadel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Avadel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is Avadel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.82)
Revenue Per Share
0.633
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.55)
Return On Equity
(7.80)
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.